Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that could favor the occurrence of small intestinal bacterial overgrowth (SIBO). The aim of the study was to assess the prevalence of SIBO in Chinese patients with PD and the potential impact of SIBO on gastrointestinal symptoms and motor function. 182 consecutive Chinese patients with PD patients and 200 sex, age, and BMI-matched subjects without PD were included. All participants underwent the glucose breath test to assess SIBO. We examined the associations between factors and SIBO with logistic regression using SPSS. Fifty-five of the 182 PD patients were SIBO positive (30.2 %; 95 % CI 23.5-36.9 %) compared with 19 of 200 in the control group (9.5 %; 95 % CI 5.4-13.6 %); the difference was statistically significant (P < 0.0001; OR 4.13; 95 % CI 2.34-7.29). Motor fluctuations present was higher in the PD patients with SIBO than in the patients without SIBO (70.9 vs. 45.7 %; P = 0.002). Multivariate analysis showed that disease duration, Hoehn and Yahr stage, Unified PD Rating-III score, Unified PD Rating-IV score, and Non-Motor Symptoms Scale score were the factors associated with the SIBO-positive status in PD patients. SIBO was highly prevalent in PD, and nearly one-third was detected. SIBO was associated with worse gastrointestinal symptoms and worse motor function. Further studies are needed to specify the reasons underlying SIBO and worse motor function in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the positive rate of small intestinal bacterial overgrowth in patients with Parkinson's disease was found to be significantly increased, and it was associated with the deterioration of gastrointestinal symptoms and motor function.61”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [61]
Citations
Cites
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · cited 1×
“The study enrolled 182 consecutive outpatients and inpatients that fulfilled the following inclusion criteria: the diagnosis of PD according to the criteria of the UK Brain Bank (Gelb et al. 1999) and the occurrence of motor fluctuations (assessed by Niu and Li).”
MethodGoetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347 · cited 1×
“Y) stage (Goetz et al. 2004).”
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 3×
“Gastrointestinal dysfunction, in particular constipation, affects up to 80 % of PD patients and may precede the onset of motor symptoms by years (Scheperjans et al. 2015).”
BackgroundInfluentialThe Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) · Movement Disorders · doi:10.1002/mds.10473 · Cited by 1,810
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445 · cited 1×
“…GI dysfunction in patients with more advanced PD. GI dysfunction seems to be the most plausible pathophysiological link underlying the association between SIBO and PD. GI motility dysfunction is manifesting mainly as dysphagia, disorders of gastric emptying, and constipation (Barone et al. 2009).”
BackgroundChaudhuri, K. R., Martinez‐Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Abe, K., MacPhee, G., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,087 · cited 4×
“Y Hoehn and Yahr, LEU levodopa equivalent units, UPDRS Unified PD Rating Scale, NMSS Non-Motor Symptoms Scale causal link between SIBO and motor function in PD.”
MethodInfluentialSmall intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620 · cited 1×
“Other potentially relevant, but hitherto unstudied, factors are geographic effects, dietary factors, including alcohol consumption, malnutrition, and possible alterations in gut and systemic immune function (Furnari et al. 2010; Bures et al. 2010).”
BackgroundROME III: The Functional Gastrointestinal Disorders
Sheth, A. A. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31804bbe26 · Cited by 489
Melancholic microbes: a link between gut microbiota and depression
Dinan, T. G., & Cryan, J. F. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12198 · Cited by 424 · cited 1×
“Furthermore, recent studies had demonstrated that there was a distinct perturbation of the composition of gut microbiota in animal models of depression and chronic stress (Dinan and Cryan 2013).”
BackgroundThe role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344 · cited 8×
“Some studies suggested that SIBO could be associated with worse ‘‘on’’-medication motor scores and more severe motor fluctuations (Gabrielli et al. 2011; Fasano et al. 2013).”
BackgroundResultInfluential
Cited by
Chen, Z., Li, G., & Liu, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104700 · Cited by 363
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266
“Intestinal microbial overgrowth, which is defined as an excessive increase in coliform bacteria, has been found to be common in PD patients (Gabrielli et al., 2011; Niu et al., 2016; Sachdev and Pimentel, 2013).”
Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
Rao, S. S. C., & Bhagatwala, J. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000078 · Cited by 198
Fu, P., Gao, M., & Yung, K. K. L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00607 · Cited by 146
Autonomic Dysfunction in Parkinson's Disease
Pfeiffer, R. F. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00897-4 · Cited by 147
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO
Banaszak, M., Górna, I., Woźniak, D., Przysławski, J., & Drzymała-Czyż, S. (2023) · Microorganisms · doi:10.3390/microorganisms11030573 · Cited by 135
Johnson, M. E., Stringer, A., & Bobrovskaya, L. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.02.013 · Cited by 122
The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO)
Quigley, E. M. M. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0671-z · Cited by 117
Epidemiology of small intestinal bacterial overgrowth
Efremova, I., Maslennikov, R. V., Poluektova, E. A., Vasilieva, E., Zharikov, Y. O., Suslov, A. V., Letyagina, Y., Kozlov, E. M., Levshina, A., & Ivashkin, V. T. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3400 · Cited by 121
Tan, W., Zhang, Q., Dong, Z., Yan, Y., Fu, Y., Liu, X., Zhao, B., & Duan, X. L. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06383 · Cited by 119
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H.-L., & Lin, C.-H. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 104
Ghoshal, U. C., Sachdeva, S., Ghoshal, U., Misra, A., Puri, A. S., Pratap, N., Shah, A., Rahman, M. M., Gwee, K. A., Tan, V. P. Y., et al. (2022) · Indian Journal of Gastroenterology · doi:10.1007/s12664-022-01292-x · Cited by 109
“A recent case-control study from China evaluated 182 patients with Parkinson’s disease and 200 controls for SIBO using GHBT [99].”
MethodXiang, Z.-B., Xu, R.-S., Zhu, Y., Yuan, M., Liu, Y., Yang, F., Chen, W.-Z., & Xu, Z.-Z. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.317981 · Cited by 93
“Moreover, a higher prevalence of small intestinal bacterial overgrowth has been observed in PD patients compared with controls without PD (Tan et al., 2014; Niu et al., 2016), and dysbiosis of the intestinal microbiome may also induce the intestinal inflammatory response (Spielman et al., 2018).”
BackgroundSarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
Cai, Y., Feng, F., Wei, Q., Jiang, Z., Ou, R., & Shang, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.598035 · Cited by 94
Tansel, A., & Levinthal, D. J. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000567 · Cited by 89
Intestinal Inflammation and Parkinson’s Disease
Li, Y., Chen, Y., Jiang, L., Zhang, J., Tong, X., Chen, D., & Le, W. (2021) · Aging and Disease · doi:10.14336/ad.2021.0418 · Cited by 80
Self-citationGiron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G. E., Bishehsari, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160989 · Cited by 79
The small intestine: dining table of host–microbiota meetings
Delbaere, K., Roegiers, I. H., Bron, A., Durif, C., de Wiele, T. V., Blanquet‐Diot, S., & Marinelli, L. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad022 · Cited by 79
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
Yemula, N., Dietrich, C. M., Dostal, V., & Hornberger, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212707 · Cited by 75
Sroka, N., Rydzewska–Rosołowska, A., Kakareko, K., Rosołowski, M., Głowińska, I., & Hryszko, T. (2022) · Nutrients · doi:10.3390/nu15010090 · Cited by 67
Li, X., Feng, X., Jiang, Z., & Jiang, Z. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00420-w · Cited by 62
“Similarly, no significant differences in the prevalence of constipation [10, 12, 13, 17] and diarrhoea [10, 12, 13, 17] were noted between PD patients with and without SIBO with ORs of 0.”
BackgroundResultJohnson, M., Salvatore, M. F., Maiolo, S., & Bobrovskaya, L. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.01.002 · Cited by 54
Roszkowska, P., Klimczak, E., Ostrycharz, E., Rączka, A., Wojciechowska‐Koszko, I., Dybus, A., Cheng, Y.-H., Yu, Y., Mazgaj, S., & Hukowska-Szematowicz, B. (2024) · Biomedicines · doi:10.3390/biomedicines12051030 · Cited by 50
The diagnostic value of SNpc using NM-MRI in Parkinson’s disease: meta-analysis
Wang, X., Zhang, Y., Zhu, C., Li, G., Kang, J., Chen, F., & Yang, L. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04014-y · Cited by 43
“According to statistics, the number of Parkinson’s disease patients in China has reached to 200 million currently [2].”
BackgroundHasuike, Y., Endo, T., Koroyasu, M., Matsui, M., Mori, C., Yamadera, M., Fujimura, H., & Sakoda, S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109436 · Cited by 42
Gut dysbiosis and age-related neurological diseases in females
Korf, J. M., Ganesh, B. P., & McCullough, L. D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105695 · Cited by 49
Tan, A. H., Chuah, K. H., Beh, Y. Y., Schee, J. P., Mahadeva, S., & Lim, S. (2023) · Journal of Movement Disorders · doi:10.14802/jmd.22220 · Cited by 45
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
Ryman, S., Vakhtin, A. A., Richardson, S. P., & Lin, H. C. (2023) · Journal of Neurology · doi:10.1007/s00415-022-11461-9 · Cited by 38
“Using this approach, ~ ½ of PD patients test positive for SIBO [37, 38] and the occurrence of SIBO was associated with more severe motor fluctuations [38, 39].”
Effects of Helicobacter pylori on Levodopa Pharmacokinetics
Nyholm, D., & Hellström, P. M. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202298 · Cited by 39
“A large study in 103 subjects using the lactulose and glucose hydrogen breath tests found SIBO to be present in 25–33% of PD patients, along with poor motor control [45, 46], and in other studies up to 67% [47, 48], but without association to GI symptoms [44].”
Wang, L., Yu, Y.-M., Zhang, Y.-Q., Zhang, J., Lu, N., & Liu, N. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1039-2 · Cited by 38
Self-citationGastrointestinal Dysfunction in Parkinson’s Disease
Safarpour, D., Sharzehi, K., & Pfeiffer, R. F. (2022) · Drugs · doi:10.1007/s40265-021-01664-1 · Cited by 40
Kalampokini, S., Becker, A., Fassbender, K. C., Lyros, E., & Unger, M. M. (2019) · Parkinson s Disease · doi:10.1155/2019/7535472 · Cited by 36
“SIBO has been associated with gastrointestinal symptoms and worse motor scores (UPDRS III) [54, 55] while there is inconsistency regarding its effects on motor fluctuations [52, 54, 55].”
BackgroundWang, W., Jiang, S., Xu, C., Tang, L., Liang, Y., Zhao, Y., & Zhu, G. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.976316 · Cited by 34
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 28
Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
Hey, G. E., Nair, N., Klann, E. M., Gurrala, A., Safarpour, D., Mai, V., Ramirez‐Zamora, A., & Vedam‐Mai, V. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1151850 · Cited by 28
“(Gabrielli et al., 2011; Niu et al., 2016; DiBaise et al., 2018), and the data on the relationship between PD symptoms and SIBO is quite heterogeneous (Fasano et al., 2013).”
BackgroundSong, Y., Liu, Y., Qi, B., Cui, X., Dong, X., Wang, Y., Han, X., Li, F., Shen, D., Zhang, X., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.119.015292 · Cited by 28
Small intestinal bacterial overgrowth in Alzheimer’s disease
Kowalski, K., & Mulak, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02440-x · Cited by 24
Zhang, Z., & Chen, S. (2020) · Parkinson s Disease · doi:10.1155/2020/8740732 · Cited by 23
“Small intestine bacteria overgrowth (SIBO) was also common in PD patients, reflecting the underlying intestinal hypomotility in PD [17].”
BackgroundPharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Zhang, Y., Mo, C., Ai, P., He, X., Xiao, Q., & Yang, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2454937 · Cited by 20
Leveraging animal models to understand non-motor symptoms of Parkinson's disease
Wichmann, T., Nelson, A., Torres, E. R. S., Svenningsson, P., & Marongiu, R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106848 · Cited by 19
“Evidence for small intestinal hypomotility is seen in about 1/3 of PD patients (Niu et al., 2016), and constipation, as a sign of large intestine involvement, is reported by 80% of PD patients (Verbaan et al., 2007).”
Weight Loss in Parkinson’s Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth
DiBaise, J. K., Crowell, M. D., Driver‐Dunckley, E. D., Mehta, S. H., Hoffman‐Snyder, C., Lin, T. P., & Adler, C. H. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181386 · Cited by 21
“Although not focusing on weight loss, the reports previously described also did not find a difference in BMI in those with and without SIBO [8, 35, 37, 38].”
Gastrointestinal dysfunction in the synucleinopathies
Chung, K. A., & Pfeiffer, R. F. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00745-7 · Cited by 19
Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
Baizabal‐Carvallo, J. F., Alonso‐Juarez, M., & Fekete, R. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.729961 · Cited by 19
“An association between SIBO and motor fluctuations may also exist, as shown in a Chinese study of 182 patients with PD (7).”
BackgroundDo Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
Koukoulis, T. F., Beauchamp, L. C., Kaparakis‐Liaskos, M., McQuade, R. M., Purnianto, A., Finkelstein, D. I., Barnham, K. J., & Vella, L. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230315 · Cited by 16
Epidemiology of autonomic dysfunction in Parkinson's disease (Review)
Rissardo, J. P., Gadelmawla, A. F., Khalil, I., Abdulgadir, A., Bhatti, K. S., & Caprara, A. L. F. (2025) · Medicine International · doi:10.3892/mi.2025.267 · Cited by 15
“Moreover, SIBo is associated with poor motor functions among patients with PD (266). one of the factors associated with a high percentage of SIBo in PD is the prolonged small intestine passage observed in almost 100% of patients (267).”
Gut microbiota: a potential therapeutic target for Parkinson’s disease
Baizabal‐Carvallo, J. F. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290896 · Cited by 12
“%) compared to PD patients without motor fluctuations (Niu et al., 2016).”
ResultLiang, X., Wang, Y., Andrikopoulos, N., Ke, P. C., & Li, Y. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01145-2 · Cited by 11
“…the pro fi le of small intestinal microbiota in an A53T α S mouse model Recent studies have reported that changes in the population of small intestinal bacteria are likely related to PD pathogenesis, highlighting the prevalence of small intestinal bacterial overgrowth (SIBO) in PD subjects 41 – 43 .”
Dopamine and Gastrointestinal Motility
Zheng, L., Liu, S., Zhou, L., Zhang, X., Xiao, Y., & Zhu, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6586-5_5 · Cited by 13
Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis
Damianos, J., Wang, X. J., & Camilleri, M. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00295-x · Cited by 8
Gastrointestinal dysfunction in Parkinson's disease
Timpka, J., & Odin, P. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.07.004 · Cited by 7
Figliomeni, A., Winter, S. J., Abonnel, M. Y., Kenna, J. E., Lodge, S., Whiley, L., Bernal, A., Coudert, J. D., Noonan, J. E., Kaskow, B. J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01212-8 · Cited by 5
Rong, H., Zhang, L., Jia-shuang, L., Liu, Y., Yi, J., & Liu, X. (2021) · Diagnostics · doi:10.3390/diagnostics11081445 · Cited by 4
The gut microbiome as a factor in the development of Parkinson's disease
Арамайисовна, Б. Л., Poluektova, E. A., & Poluektov, M. G. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-1-90-96 · Cited by 4
Die Rolle des Darmmikrobioms beim idiopathischen Parkinson-Syndrom
Unger, M. M., Becker, A., Keller, A., Schäfer, K., Schwiertz, A., & Oertel, W. H. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-01011-x · Cited by 3
Kim, D. B., Park, C., Paik, C. N., Kang, Y. J., Jo, I. H., & Lee, J. M. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_134_22 · Cited by 3
Small Intestinal Bacterial Overgrowth Syndrome
Dharmarajan, T. S., & Pitchumoni, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_62 · Cited by 3
Small Intestinal Bacterial Overgrowth Syndrome
Dharmarajan, T. S., & Pitchumoni, C. S. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_62-1 · Cited by 1
Li, X., Feng, X., & Jiang, Z. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00703
ФУНКЦІОНАЛЬНИЙ СТАН ВЕГЕТАТИВНОЇ НЕРВОВОЇ СИСТЕМИ У ХВОРИХ НА ХВОРОБУ ПАРКІНСОНА
Хубетова, И. В. (2022) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2022.v.i1.13007
Norouzy, A., Mohamadinarab, M., & Kalayeh, H. M. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00046-5
İlhan, S. (2024) · Journal of Immunology and Clinical Microbiology · doi:10.58854/jicm.1583436
Plasma-Derived Biomarkers of Parkinson Disease: MicroRNAs
Flores, R. J. D. (2026) · Otago University Research Archive (University of Otago) · doi:10.82348/our-archive.00437
Metadata
- Authors
- Niu, X.-L., Liu, L., Song, Z.-X., Li, Q., Wang, Z.-H., Zhang, J.-L., & Li, H.-H.
- Affiliations
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Venue
- Journal of Neural Transmission
- Published
- 2016-09-02
- Volume
- 123
- Issue
- 12
- Pages
- 1381-1386
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2510141755
- Semantic Scholar
- 9f9ee3e308ae31d9ea9d8acebe6bc2734ceb8cd5
- Cited by
- 64
- References
- 27
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 1
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Parkinson's disease, small intestinal bacterial overgrowth, prevalence, gastrointestinal motility, motor fluctuations, motor function, non-motor symptoms, disease duration, Hoehn and Yahr stage, Chinese patients
- MeSH terms
- Gastrointestinal Microbiome, Aged, Blind Loop Syndrome, Breath Tests, Female, Humans, Intestine, Small, Male, Middle Aged, Parkinson Disease, Body Mass Index, Prevalence, Case-Control Studies, Statistics, Nonparametric, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.